Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis

Research

Shalini L Kulasingam^*, Steve Benard, Ruanne V Barnabas, Nathalie Largeron and Evan R Myers

Cost Effectiveness and Resource Allocation 2008, 6:4 doi:10.1186/1478-7547-6-4

No comments have yet been made on this article.